APO RESEARCH · REPORT
Drug-coated Balloon (DCB)
A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.
Product & engineering
Understand the product.
A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.
Selected research
Industry Research
Drug-coated Balloon (DCB) Industry Research Report 2026
Market perspective
A drug-coated balloon (DCB) is an angioplasty balloon catheter in which an antiproliferative drug is coated onto the balloon surface and delivered to the vessel wall during transient balloon inflation, providing a localized therapeutic effect while leaving no permanent implant behind. The coating is engineered to remain stable on the balloon during tracking and deployment, then rapidly transfer an effective dose into the arterial tissue upon inflation, with the drug retained in the vessel wall to suppress neointimal hyperplasia and reduce restenosis after percutaneous transluminal angioplasty. In clinical use, DCB technology is applied across coronary and peripheral interventions, including femoropopliteal and below-the-knee vessels and selected dialysis-access lesions, and its performance is defined by the balance between deliverability, tissue drug transfer efficiency, and the control of downstream loss of coating material during the procedure.
The global Drug-coated Balloon (DCB) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Drug-coated Balloon (DCB) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
Read the full market overview
The Europe market for Drug-coated Balloon (DCB) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Drug-coated Balloon (DCB) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Drug-coated Balloon (DCB) include Medtronic, Boston Scientific, Becton Dickinson, Biotronik, B. Braun, Philips, Abbott, Eurocor and Yinyi Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Drug-coated Balloon (DCB) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug-coated Balloon (DCB) Market by Company
Medtronic
Boston Scientific
Becton Dickinson
Biotronik
B. Braun
Philips
Abbott
Eurocor
Yinyi Biotech
Lepu Medical
Grand Pharma
Acotec Scientific
Shenqi Medical
MicroPort
Zylox-Tonbridge Medical
Zhejiang Barty Medical
Drug-coated Balloon (DCB) Segment by Type
Coronary DCB
Peripheral DCB (FP)
Peripheral DCB (BTK)
Drug-coated Balloon (DCB) Segment by Application
Dialysis Access (AVF/AVG)
Femoropopliteal (FP)
Below-the-Knee (BTK)
Drug-coated Balloon (DCB) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-coated Balloon (DCB) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug-coated Balloon (DCB) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-coated Balloon (DCB).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug-coated Balloon (DCB) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug-coated Balloon (DCB) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug-coated Balloon (DCB) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Coronary DCB
- Peripheral DCB (FP)
- Peripheral DCB (BTK)
Applications
- Dialysis Access (AVF/AVG)
- Femoropopliteal (FP)
- Below-the-Knee (BTK)
Companies covered
- Medtronic
- Boston Scientific
- Becton Dickinson
- Biotronik
- B. Braun
- Philips
- Abbott
- Eurocor
- Yinyi Biotech
- Lepu Medical
- Grand Pharma
- Acotec Scientific
- Shenqi Medical
- MicroPort
- Zylox-Tonbridge Medical
- Zhejiang Barty Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Drug-coated Balloon (DCB) Market Size (2021-2032)
- 2.2.2 Global Drug-coated Balloon (DCB) Sales (2021-2032)
- 2.2.3 Global Drug-coated Balloon (DCB) Market Average Price (2021-2032)
- 2.3 Drug-coated Balloon (DCB) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Coronary DCB
- 2.3.3 Peripheral DCB (FP)
- 2.3.4 Peripheral DCB (BTK)
- 2.4 Drug-coated Balloon (DCB) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dialysis Access (AVF/AVG)
- 2.4.3 Femoropopliteal (FP)
- 2.4.4 Below-the-Knee (BTK)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Drug-coated Balloon (DCB) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Drug-coated Balloon (DCB) Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Drug-coated Balloon (DCB) Revenue of Manufacturers (2021-2026)
- 3.4 Global Drug-coated Balloon (DCB) Average Price by Manufacturers (2021-2026)
- 3.5 Global Drug-coated Balloon (DCB) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Drug-coated Balloon (DCB), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Drug-coated Balloon (DCB), Product Type & Application
- 3.8 Global Manufacturers of Drug-coated Balloon (DCB), Established Date
- 3.9 Global Drug-coated Balloon (DCB) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Drug-coated Balloon (DCB) Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 Boston Scientific
- 4.2.1 Boston Scientific Company Information
- 4.2.2 Boston Scientific Business Overview
- 4.2.3 Boston Scientific Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boston Scientific Drug-coated Balloon (DCB) Product Portfolio
- 4.2.5 Boston Scientific Recent Developments
- 4.3 Becton Dickinson
- 4.3.1 Becton Dickinson Company Information
- 4.3.2 Becton Dickinson Business Overview
- 4.3.3 Becton Dickinson Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Becton Dickinson Drug-coated Balloon (DCB) Product Portfolio
- 4.3.5 Becton Dickinson Recent Developments
- 4.4 Biotronik
- 4.4.1 Biotronik Company Information
- 4.4.2 Biotronik Business Overview
- 4.4.3 Biotronik Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Biotronik Drug-coated Balloon (DCB) Product Portfolio
- 4.4.5 Biotronik Recent Developments
- 4.5 B. Braun
- 4.5.1 B. Braun Company Information
- 4.5.2 B. Braun Business Overview
- 4.5.3 B. Braun Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 B. Braun Drug-coated Balloon (DCB) Product Portfolio
- 4.5.5 B. Braun Recent Developments
- 4.6 Philips
- 4.6.1 Philips Company Information
- 4.6.2 Philips Business Overview
- 4.6.3 Philips Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Philips Drug-coated Balloon (DCB) Product Portfolio
- 4.6.5 Philips Recent Developments
- 4.7 Abbott
- 4.7.1 Abbott Company Information
- 4.7.2 Abbott Business Overview
- 4.7.3 Abbott Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Abbott Drug-coated Balloon (DCB) Product Portfolio
- 4.7.5 Abbott Recent Developments
- 4.8 Eurocor
- 4.8.1 Eurocor Company Information
- 4.8.2 Eurocor Business Overview
- 4.8.3 Eurocor Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Eurocor Drug-coated Balloon (DCB) Product Portfolio
- 4.8.5 Eurocor Recent Developments
- 4.9 Yinyi Biotech
- 4.9.1 Yinyi Biotech Company Information
- 4.9.2 Yinyi Biotech Business Overview
- 4.9.3 Yinyi Biotech Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Yinyi Biotech Drug-coated Balloon (DCB) Product Portfolio
- 4.9.5 Yinyi Biotech Recent Developments
- 4.10 Lepu Medical
- 4.10.1 Lepu Medical Company Information
- 4.10.2 Lepu Medical Business Overview
- 4.10.3 Lepu Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lepu Medical Drug-coated Balloon (DCB) Product Portfolio
- 4.10.5 Lepu Medical Recent Developments
- 4.11 Grand Pharma
- 4.11.1 Grand Pharma Company Information
- 4.11.2 Grand Pharma Business Overview
- 4.11.3 Grand Pharma Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Grand Pharma Drug-coated Balloon (DCB) Product Portfolio
- 4.11.5 Grand Pharma Recent Developments
- 4.12 Acotec Scientific
- 4.12.1 Acotec Scientific Company Information
- 4.12.2 Acotec Scientific Business Overview
- 4.12.3 Acotec Scientific Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Acotec Scientific Drug-coated Balloon (DCB) Product Portfolio
- 4.12.5 Acotec Scientific Recent Developments
- 4.13 Shenqi Medical
- 4.13.1 Shenqi Medical Company Information
- 4.13.2 Shenqi Medical Business Overview
- 4.13.3 Shenqi Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Shenqi Medical Drug-coated Balloon (DCB) Product Portfolio
- 4.13.5 Shenqi Medical Recent Developments
- 4.14 MicroPort
- 4.14.1 MicroPort Company Information
- 4.14.2 MicroPort Business Overview
- 4.14.3 MicroPort Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 MicroPort Drug-coated Balloon (DCB) Product Portfolio
- 4.14.5 MicroPort Recent Developments
- 4.15 Zylox-Tonbridge Medical
- 4.15.1 Zylox-Tonbridge Medical Company Information
- 4.15.2 Zylox-Tonbridge Medical Business Overview
- 4.15.3 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Zylox-Tonbridge Medical Drug-coated Balloon (DCB) Product Portfolio
- 4.15.5 Zylox-Tonbridge Medical Recent Developments
- 4.16 Zhejiang Barty Medical
- 4.16.1 Zhejiang Barty Medical Company Information
- 4.16.2 Zhejiang Barty Medical Business Overview
- 4.16.3 Zhejiang Barty Medical Drug-coated Balloon (DCB) Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Zhejiang Barty Medical Drug-coated Balloon (DCB) Product Portfolio
- 4.16.5 Zhejiang Barty Medical Recent Developments
5 Global Drug-coated Balloon (DCB) Market Scenario by Region
- 5.1 Global Drug-coated Balloon (DCB) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Drug-coated Balloon (DCB) Sales by Region: 2021-2032
- 5.2.1 Global Drug-coated Balloon (DCB) Sales by Region: 2021-2026
- 5.2.2 Global Drug-coated Balloon (DCB) Sales by Region: 2027-2032
- 5.3 Global Drug-coated Balloon (DCB) Revenue by Region: 2021-2032
- 5.3.1 Global Drug-coated Balloon (DCB) Revenue by Region: 2021-2026
- 5.3.2 Global Drug-coated Balloon (DCB) Revenue by Region: 2027-2032
- 5.4 North America Drug-coated Balloon (DCB) Market Facts & Figures by Country
- 5.4.1 North America Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Drug-coated Balloon (DCB) Sales by Country (2021-2032)
- 5.4.3 North America Drug-coated Balloon (DCB) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Drug-coated Balloon (DCB) Market Facts & Figures by Country
- 5.5.1 Europe Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Drug-coated Balloon (DCB) Sales by Country (2021-2032)
- 5.5.3 Europe Drug-coated Balloon (DCB) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Drug-coated Balloon (DCB) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Drug-coated Balloon (DCB) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Drug-coated Balloon (DCB) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Drug-coated Balloon (DCB) Market Facts & Figures by Country
- 5.7.1 South America Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Drug-coated Balloon (DCB) Sales by Country (2021-2032)
- 5.7.3 South America Drug-coated Balloon (DCB) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Drug-coated Balloon (DCB) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Drug-coated Balloon (DCB) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Drug-coated Balloon (DCB) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Drug-coated Balloon (DCB) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Drug-coated Balloon (DCB) Sales by Type (2021-2032)
- 6.1.1 Global Drug-coated Balloon (DCB) Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Drug-coated Balloon (DCB) Sales Market Share by Type (2021-2032)
- 6.2 Global Drug-coated Balloon (DCB) Revenue by Type (2021-2032)
- 6.2.1 Global Drug-coated Balloon (DCB) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Drug-coated Balloon (DCB) Revenue Market Share by Type (2021-2032)
- 6.3 Global Drug-coated Balloon (DCB) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Drug-coated Balloon (DCB) Sales by Application (2021-2032)
- 7.1.1 Global Drug-coated Balloon (DCB) Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Drug-coated Balloon (DCB) Sales Market Share by Application (2021-2032)
- 7.2 Global Drug-coated Balloon (DCB) Revenue by Application (2021-2032)
- 7.2.1 Global Drug-coated Balloon (DCB) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Drug-coated Balloon (DCB) Revenue Market Share by Application (2021-2032)
- 7.3 Global Drug-coated Balloon (DCB) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Drug-coated Balloon (DCB) Value Chain Analysis
- 8.1.1 Drug-coated Balloon (DCB) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Drug-coated Balloon (DCB) Production Mode & Process
- 8.2 Drug-coated Balloon (DCB) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Drug-coated Balloon (DCB) Distributors
- 8.2.3 Drug-coated Balloon (DCB) Customers
9 Global Drug-coated Balloon (DCB) Analyzing Market Dynamics
- 9.1 Drug-coated Balloon (DCB) Industry Trends
- 9.2 Drug-coated Balloon (DCB) Industry Drivers
- 9.3 Drug-coated Balloon (DCB) Industry Opportunities and Challenges
- 9.4 Drug-coated Balloon (DCB) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst